Publications by authors named "Virginia Bove"

Claim this Profile
M
Myelodysplastic syndrome with dual germline RUNX1 and DDX41 variants: a rare genetic predisposition case.
Virginia Bove, Maria Noel Spangenberg, Carolina Ottati, Lucia Vázquez, Ana I Catalán

Fam Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Analysis of Newly Diagnosed Multiple Myeloma Patients after Frontline Autologous Stem Cell Transplantation in a Real-Life Setting.
David Garrido, Virginia Bove, Fiorella Villano, Eloísa Riva

Acta Medica (Hradec Kralove)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology and risk factors for the development of infectious complications in newly diagnosed multiple myeloma: a multicenter prospective cohort study in Uruguay.
Eloísa Riva, David Garrido, Fiorella Villano, Virginia Bove

Hematol Transfus Cell Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients Age 40 Years and Younger With Multiple Myeloma Have the Same Prognosis as Older Patients: An Analysis of Real-World Patients' Evidence From Latin America.
Humberto Martínez-Cordero, Camila Peña, Natalia Paola Schutz, Virginia Bove, Fiorella Villano

JCO Glob Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary plasma cell leukemia in Latin America: demographic, clinical, and prognostic characteristics. A study of GELAMM group.
Camila Peña, Eloísa Riva, Natalia Schutz, Aline Ramírez, Jule Vásquez, Virginia Bove

Leuk Lymphoma· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study.
Eloísa Riva, Patricio José Duarte, Bryan Valcárcel, Guillermina Remaggi, Ivan Murrieta, Virginia Bove

JCO Glob Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology and Risk Factors for the Development of Infectious Complications in Newly Diagnosed Multiple Myeloma: A Multicenter Prospective Cohort Study in Latin America.
Virginia Bove, Eloísa Riva, Jule Vásquez, Camila Peña, Cristian Seehaus

JCO Glob Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative survival analysis using the International Stratification Score (ISS) in newly-diagnosed multiple myeloma in the Uruguayan population.
David Israel Garrido, Virginia Bove, Victoria Matosas, Eloisa Riva

Med Pharm Rep· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study.
Camila Peña, Eloisa Riva, Natalia Schutz, Luz Tarín-Arzaga, Humberto Martínez-Cordero, Virginia Bove

Leuk Lymphoma· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Young age and autologous stem cell transplantation are associated with improved survival in newly diagnosed multiple myeloma.
Virginia Bove, David Garrido, Eloisa Riva

Hematol Transfus Cell Ther· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis